Home / News / Johnson & Johnson’s COVID-19 Vaccine Is 66% Effective Overall, Over 50% on Emerging Variants / Johnson-Johnson-vaccine
Recent Posts
- NJ ACTS Special Populations Virtual Seminar on 9/24 at 12pm – Register Now
- NJ ACTS CREST (R25) Funded
- NJ ACTS Workforce Development Internship Fall 2024 – Deadline Today
- NJ ACTS Workforce Development Internship Fall 2024 – Deadline Today
- Rutgers Health Researchers Find Disparities in Outcomes of Hospice Discharges.
Categories
- News (2,181)
- Publication (1)